The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
Authors
Keywords
-
Journal
BMC Psychiatry
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-30
DOI
10.1186/s12888-022-04388-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
- (2021) Jason Ng et al. PSYCHOPHARMACOLOGY
- Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial
- (2021) Jennifer B. Dwyer et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effect of SSRIs on Resting-State Functional Brain Networks in Adolescents with Major Depressive Disorder
- (2021) Shu-Hsien Chu et al. Journal of Clinical Medicine
- Parental Attitudes Toward Use of Ketamine in Adolescent Mood Disorders and Suicidality
- (2021) David S. Mathai et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Structural brain correlates in major depression, anxiety disorders and post-traumatic stress disorder: A voxel-based morphometry meta-analysis
- (2021) Maria Serra-Blasco et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
- (2021) Sanne Y. Smith-Apeldoorn et al. BJPsych Open
- Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients
- (2020) Laura Basso et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis
- (2020) Yan-Ling Zhou et al. Translational Psychiatry
- Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
- (2020) Anees Bahji et al. JOURNAL OF AFFECTIVE DISORDERS
- A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation
- (2019) Yanni Zhan et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Treatment-resistant depression and peripheral C-reactive protein
- (2018) Samuel R. Chamberlain et al. BRITISH JOURNAL OF PSYCHIATRY
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study
- (2018) Kathryn R. Cullen et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
- (2018) Deborah S. Hasin et al. JAMA Psychiatry
- Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
- (2018) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Ketamine as a Treatment for Adolescent Depression: A Case Report
- (2017) Jennifer B. Dwyer et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression
- (2017) Chanjuan Zhou et al. PLoS One
- Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
- (2016) Cristina Cusin et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Oral ketamine for the treatment of pain and treatment-resistant depression
- (2016) Robert A. Schoevers et al. BRITISH JOURNAL OF PSYCHIATRY
- SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM
- (2016) Jorge Lopez-Castroman et al. DEPRESSION AND ANXIETY
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
- (2016) Morteza Jafarinia et al. JOURNAL OF AFFECTIVE DISORDERS
- Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study
- (2016) Renan Boeira Rocha et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing
- (2015) Samuel Fanta et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis
- (2015) Ellen E. Lee et al. GENERAL HOSPITAL PSYCHIATRY
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- (2013) Alize J. Ferrari et al. PLOS MEDICINE
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- A systematic review of resting-state functional-MRI studies in major depression
- (2012) L. Wang et al. JOURNAL OF AFFECTIVE DISORDERS
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Bladder Pain/Interstitial Cystitis Symptom Score: Development, Validation, and Identification of a Cut Score
- (2011) Louise Humphrey et al. EUROPEAN UROLOGY
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
- (2011) Jonas Hannestad et al. NEUROPSYCHOPHARMACOLOGY
- Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
- (2011) Michele Fornaro et al. Neuropsychiatric Disease and Treatment
- Incidence and Predictors of Suicide Attempts in DSM–IV Major Depressive Disorder: A Five-Year Prospective Study
- (2010) K. Mikael Holma et al. AMERICAN JOURNAL OF PSYCHIATRY
- Perceptions and Awareness of Electroconvulsive Therapy Among Patients and Their Families
- (2010) Subho Chakrabarti et al. JOURNAL OF ECT
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive Side Effects of Brief Pulse Electroconvulsive Therapy
- (2008) Anna Ingram et al. JOURNAL OF ECT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started